A Dark Vector Cognition product

Cover and table of contents

9K characters. Original on sec.gov ·

Cover and table of contents

The 7 tables in Cover and table of contents as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 1-11373

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

Ohio31-0958666
(State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.)
7000 Cardinal Place,Dublin,Ohio43017
(Address of principal executive offices)(Zip Code)

(614) 757-5000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer☑Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of the registrant’s common shares, without par value, outstanding as of October 31, 2026, was the following: 231,136,655.

Cardinal Health Q1 Fiscal 2027 Form 10-Q

Table of Contents

Page
Introduction2
Management's Discussion and Analysis of Financial Condition and Results of Operations3
About Cardinal Health3
Overview of Consolidated Results4
Significant Developments in Fiscal 2027 and Trends5
Results of Operations7
Liquidity and Capital Resources11
Other Items13
Critical Accounting Policies and Sensitive Accounting Estimates13
Explanation and Reconciliation of Non-GAAP Financial Measures14
Quantitative and Qualitative Disclosures about Market Risk17
Controls and Procedures17
Legal Proceedings18
Risk Factors18
Unregistered Sales of Equity Securities and Use of Proceeds18
Other Information18
Financial Statements and Supplementary Data19
Notes to Consolidated Financial Statements24
Exhibits37
Form 10-Q Cross Reference Index38
Signatures39
Cardinal Health | Q1 Fiscal 2027 Form 10-Q1

Next: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations